OJOG  Vol.5 No.1 , January 2015
Expression of Messenger RNA of Oncoproteins E6 and E7 of Human Papilomavirus in Women with Negative Oncotic Cytologies, Epithelial Squamous Atypias of Undefined Significance and Low-Grade Intraepithelial Lesions
Abstract: Objectives: To verify the prevalence of E6/E7 RNAm expression of HPV in patients with negative cervicovaginal cytology, ASC-US and LSIL; to correlate with negative anatomopathological exams and/or squamous intraepithelial neoplasy grade I (SIN 1) of the lower genital tract (LGT); to relate the RNAm expression with viral infection types; to assess the genotyping in single infections. Methods: Findings from 825 women submitted to E6/E7 RNAm survey and 422 women submitted to LGT biopsies were analyzed. Results: A larger percentage of E6/E7 in ASC-US and LSIL cytologies occurred. Negative results of RNAm expression were in accordance with negative cytologies and negative anatomopathological exam. In positive cases, the infection by a single HPV type was most prevalent, with the type 16 being the most common. Conclusions: the expression of mRNA was most prevalent in ASC-US and LSIL cytologies, comparing with the negative ones. The findings of SIN 1 biopsies were related to the positive expression of mRNA and negative cytologies; the negative expression was in agreement with negative anatomopathological exam. The infection by a HPV type was more frequent in cases of positive expression, the HPV type 16 being most frequently found. Patients with low grade intraepithelial lesion cytologies had a higher percentage of multiple infections.
Cite this paper: Casagrande, D. , Ribalta, J. , Leite, K. , Schimidt, M. and Speck, N. (2015) Expression of Messenger RNA of Oncoproteins E6 and E7 of Human Papilomavirus in Women with Negative Oncotic Cytologies, Epithelial Squamous Atypias of Undefined Significance and Low-Grade Intraepithelial Lesions. Open Journal of Obstetrics and Gynecology, 5, 36-43. doi: 10.4236/ojog.2015.51006.

[1]   World Health Organization (2009) World Health Statistic.

[2]   INCA. Instituto Nacional do Cancer (2014) Ministério da Saúde. Estimativa 2014: Incidência de cancer no Brasil. Rio de Janeiro.

[3]   Stanley, M. (2010) Pathology and Epidemiology of HPV Infection in Females. Gynecologic Oncology, 117, S5-S10.

[4]   Kjaer, S.K., den Brule, J.C., Paull, G., Svare, E.I., Sherman, M.E., Thomsen, H.L., et al. (2002) Type Specific Persistence of High Risk Human Papillomavirus (HPV) as Indicator of High Grade Cervical Squamous Intraepithelial Lesions in Young Women: Population Based Prospective Follow up Study. British Medical Journal, 325, 1-7.

[5]   Panatto, D., Amicizia, D., Trucchi, C., Casabona, F., Lai, P.L., Bonanni, P., et al. (2012) Sexual Behavior and Risk Factors for the Acquisition of Human Papillomavirus Infections in Young People in Italy: Suggestions for Future Vaccination Policies. BMC Public Health, 12, 623.

[6]   Bosch, F.X. and de Sanjosé, S. (2007) The Epidemiology of Human Papillomavirus Infection and Cervical Cancer. Disease Markers, 23, 213-227.

[7]   Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., et al. (2009) A Review of Humans Carcinogens—Part B: Biological Agents. The Lancet Oncology, 10, 321-322.

[8]   Castellsagué, X. (2008) Natural History and Epidemiology of HPV Infection and Cervical Cancer. Gynecologic Oncology, 110, S4-S7.

[9]   Munoz, N., Bosch, F.X., de Sanjose, S., et al. (2003) Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. The New England Journal of Medicine, 348, 518-527.

[10]   Moody, C.A. and Laimins, L.A. (2010) Human Papillomavirus Oncoproteins: Pathways to Transformation. Nature Reviews Cancer, 10, 550-560.

[11]   Martin, C.M. and O'Leary, J.J. (2011) Histology of Cervical Intraepithelial Neoplasia and the Role of Biomarkers. Best Practice & Research Clinical Obstetrics and Gynecology, 25, 605-615.

[12]   Brown, A.J. and Trimble, C.L. (2012) New Technologies for Cervical Cancer Screening. Best Practice & Research Obstetrics and Gynaecology, 26, 233-242.

[13]   Tornesello, M.L., Buonaguro, L., Giorgi-Rossi, P. and Buonaguro, F.M. (2013) Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer. BioMed Research International, 1-10.

[14]   Molden, T., Kraus, I., Karlsen, F., Skomedal, H. and Hagmar, B. (2006) Human Papillomavirus E6/E7 mRNA Expression in Women Younger than 30 Years of Age. Gynecologic Oncology, 100, 95-100.

[15]   Jeantet, D., Schwarzmann, F., Tromp, J., Melchers, W.J.G., van der Wurff, A., Oosterlaken, T., et al. (2009) NucliSENS? EasyQ? HPV v1 Test—Testing for Oncogenic Activity of Human Papillomaviruses. Journal of Clinical Virology, 45, S29-S37.

[16]   Rijkaart, D.C., Heildeman, D.A.M., Cupe, V.M.H., Brink, A.A.T.P., Verheijen, R.H.M., Skomedal, H., et al. (2012) High-Risk Human Papillomavirus (hrHPV) E6/ E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cervical among hrHPV DNA-Positive Women with Normal Cytology. Journal of Clinical Microbiology, 50, 2390-2396.

[17]   Castro, S.P., Fernández, A.I., González, M.J., Sarán Diez, M.T., Lama, A.C., Martín, M.J.A., et al. (2013) Human Papillomavirus (HPV) E6/E7 mRNA as a Triage Test after Detection of HPV 16 and HPV 18 DNA. Journal of Medical Virology, 85, 1063-1068.

[18]   Andersson, S., Hansson, B., Norman, I., Gaberi, V., Mints, M., Hjerpe, A., et al. (2006) Expression of E6/E7 mRNA from “High Risk” Human Papillomavirus in Relation to CIN Grade, Viral Load and p16INK4a. International Journal of Oncology, 29, 705-711.

[19]   Brismar-Wendel, S., Froberg, M., Hjerpe, A., Anderson, S. and Johansson, B. (2009) Age-Specific Prevalence of HPV Genotypes in Cervical Cytology Samples with Equivocal or Low-Grade Lesions. British Journal of Cancer, 101, 511-517.

[20]   Spinillo, A., Dal Bello, B., Garddella, B., Roccio, M., Dacco, M.D. and Silini, E.M. (2009) Multiple Human Papillomavirus Infection and High Grade Cervical Intraepithelial Neoplasia among Women with Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low Grade Squamous Intraepithelial Lesions. Gynecologic Oncology, 113, 115-119.

[21]   Correnti, M., Medina, F., Cavazza, M.E., Rennola, A., ávila, M. and Fernándes, A. (2011) Human Papillomavirus (HPV) Type Distribution in Cervical Carcinoma, Low-Grade, and High-Grade Squamous Intraepithelial Lesions in Venezuelan Women. Gynecologic Oncology, 121, 527-531.

[22]   Gargiulo, F., De Francesco, M.A., Schreiber, C., Ciravolo, G., Salinaro, F., Valloncini, B., et al. (2007) Prevalence and Distribution of Single and Multiple HPV Infections in Cytologically Abnormal Cervical Samples from Italian Women. Virus Research, 125, 176-182.

[23]   Carozzi, F.M., Tornesello, M.L., Burroni, E., Loquercio, G., Carillo, G., Angeloni, C., et al. (2010) Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy. Cancer Epidemiology, Biomarkers & Prevention, 19, 2389-2400.

[24]   Sorbye, S.W., Arbyn, M., Fismen, S., Gutteberg, T.J. and Mortesen, E.S. (2011) Triage of Women with Low-Grade Cervical Lesions—HPV mRNA Testing versus Repeat Cytology. PLoS ONE, 6, e24083.

[25]   Keegan, H., Inerney, J.M., Pilkington, L., Gronn, P., Silva, I., Karlsen, F., et al. (2009) Comparation of HPV Detection Technologies: Hybrid Capture 2, PreTect HPV-Proffer and Analysis of HPV DNA Viral in HPV 16, HPV 18 and HVP 33 E6/E7 mRNA Positive Specimens. Journal of Virological Methods, 155, 61-66.